U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C10H14N2O2S.ClH
Molecular Weight 262.756
Optical Activity UNSPECIFIED
Defined Stereocenters 2 / 2
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of AZD-9684 HYDROCHLORIDE

SMILES

Cl.C[C@@H](S)[C@@H](CC1=CN=C(N)C=C1)C(O)=O

InChI

InChIKey=AFSZUHJNOHISGY-CIRBGYJCSA-N
InChI=1S/C10H14N2O2S.ClH/c1-6(15)8(10(13)14)4-7-2-3-9(11)12-5-7;/h2-3,5-6,8,15H,4H2,1H3,(H2,11,12)(H,13,14);1H/t6-,8-;/m1./s1

HIDE SMILES / InChI

Molecular Formula C10H14N2O2S
Molecular Weight 226.295
Charge 0
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 2 / 2
E/Z Centers 0
Optical Activity UNSPECIFIED

Molecular Formula ClH
Molecular Weight 36.461
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Approval Year

PubMed

PubMed

TitleDatePubMed
Evaluation of the enantioselectivity of glycogen-based dual chiral selector systems towards basic drugs in capillary electrophoresis.
2010-11-05
The biosynthesis of papaverine proceeds via (S)-reticuline.
2010-08
Determination of atracurium, cisatracurium and mivacurium with their impurities in pharmaceutical preparations by liquid chromatography with charged aerosol detection.
2010-02-19
Laudanosine has no effects on respiratory activity but induces non-respiratory excitement activity in isolated brainstem-spinal cord preparation of neonatal rats.
2010
Use of intrathecal and intravenous clonidine in a case of severe tetanus with acute renal failure.
2009-04
Bis-tetrahydroisoquinoline derivatives: AG525E1, a new step in the search for non-quaternary non-peptidic small conductance Ca(2+)-activated K(+) channel blockers.
2008-06-01
Applicability of ultra-performance liquid chromatography-tandem mass spectrometry for heroin profiling.
2008-04-25
[Absorption of papaverine, laudanosine and cepharanthine across human intestine by using human Caco-2 cells monolayers model].
2008-02
Synthesis of carbon-11 labeled 1-(3,4-dimethoxybenzyl)-2,2-dimethyl-1,2,3,4-tetrahydroisoquinolinium derivatives as new potential PET SKCa channel imaging agents.
2008-02
Clinical review: Drug metabolism and nonrenal clearance in acute kidney injury.
2008
Bioactive constituents of the roots of Polyalthia cerasoides.
2007-09
Simultaneous determination of atracurium and its metabolite laudanosine in post-mortem fluids by liquid chromatography/multiple-stage mass spectrometry on an ion trap.
2007
Anesthesiologist suicide with atracurium.
2006-03
Chiral separation of norlaudanosoline, laudanosoline, laudanosine, chlorthalidone, and three benzoin derivatives using amino acid based molecular micelles.
2006-02
SK channels control the firing pattern of midbrain dopaminergic neurons in vivo.
2005-12
Evaluation of benzyltetrahydroisoquinolines as ligands for neuronal nicotinic acetylcholine receptors.
2005-09
Perinatal neuroprotection by muscle relaxants against hypoxic-ischemic lesions: is it a possible hypothesis?
2005-08
Synthesis and biological evaluation of N-methyl-laudanosine iodide analogues as potential SK channel blockers.
2005-02-15
Transformation of opium poppy (Papaver somniferum L.) with antisense berberine bridge enzyme gene (anti-bbe) via somatic embryogenesis results in an altered ratio of alkaloids in latex but not in roots.
2004-12
The efficient synthesis of morphinandienone alkaloids by using a combination of hypervalent iodine(III) reagent and heteropoly acid.
2004-10-11
Instability of pancuronium in postmortem blood and liver taken after a fatal intramuscular Pavulon injection.
2004-07-16
The insulin pump as murder weapon: a case report.
2004-06
The GC-MS detection and characterization of reticuline as a marker of opium use.
2004-05-28
The GC-MS detection and characterization of reticuline as a marker of opium use.
2004-03-10
Identification and quantitation of six non-depolarizing neuromuscular blocking agents by LC-MS in biological fluids.
2004-03
Aporphine alkaloids from Guatteria spp. with leishmanicidal activity.
2003-07
The possible neuroprotective effect of laudanosine, an atracurium and cisatracurium metabolite.
2003-07
Cerebrospinal fluid concentrations of atracurium, laudanosine and vecuronium following clinical subarachnoid hemorrhage.
2002-11
Methyl-laudanosine: a new pharmacological tool to investigate the function of small-conductance Ca(2+)-activated K(+) channels.
2002-09
Pharmacodynamics and atracurium and laudanosine concentrations during a fixed continuous infusion of atracurium in mechanically ventilated patients with acute respiratory distress syndrome.
2002-08
Colominic acid: a novel chiral selector for capillary electrophoresis of basic drugs.
2002-07-12
Laudanosine, an atracurium and cisatracurium metabolite.
2002-07
Does ester hydrolysis change the in vitro degradation rate of cisatracurium and atracurium?
2002-04
Concentration-effect relationship of cisatracurium at three different dose levels in the anesthetized patient.
2001-08
The pharmacokinetics of cisatracurium in patients with acute respiratory distress syndrome.
2001-08
Inhibitory effects of ethaverine, a homologue of papaverine, on monoamine oxidase activity in mouse brain.
2001-07
Blockade and activation of the human neuronal nicotinic acetylcholine receptors by atracurium and laudanosine.
2001-04
Pharmacokinetic-pharmacodynamic modeling of atracurium in intensive care patients.
2001-01
Laudanosine and atracurium concentrations in a patient receiving long-term atracurium infusion.
1998-01
Substance Class Chemical
Created
by admin
on Tue Apr 01 18:44:13 GMT 2025
Edited
by admin
on Tue Apr 01 18:44:13 GMT 2025
Record UNII
AR85ERZ2P9
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
AZD-9684 HYDROCHLORIDE
Common Name English
AZD9684 HYDROCHLORIDE
Preferred Name English
(2S,3R)-2-((6-AMINO-3-PYRIDYL)METHYL)-3-SULFANYL-BUTANOIC ACID HYDROCHLORIDE
Systematic Name English
3-PYRIDINEPROPANOIC ACID, 6-AMINO-.ALPHA.-((1R)-1-MERCAPTOETHYL)-, HYDROCHLORIDE (1:1), (.ALPHA.S)-
Systematic Name English
Code System Code Type Description
CAS
305328-84-1
Created by admin on Tue Apr 01 18:44:13 GMT 2025 , Edited by admin on Tue Apr 01 18:44:13 GMT 2025
PRIMARY
FDA UNII
AR85ERZ2P9
Created by admin on Tue Apr 01 18:44:13 GMT 2025 , Edited by admin on Tue Apr 01 18:44:13 GMT 2025
PRIMARY
PUBCHEM
163203619
Created by admin on Tue Apr 01 18:44:13 GMT 2025 , Edited by admin on Tue Apr 01 18:44:13 GMT 2025
PRIMARY